Joseph Shulman Rhythm Pharmaceuticals, Inc. (RYTM) insider trading activity

Joseph Shulman is Chief Technical Officer of RHYTHM PHARMACEUTICALS, INC.. Currently has a direct ownership of 8,509 shares of RYTM, which is worth approximately $490,799. The most recent transaction as insider was on Feb 09, 2024, when has been sold 71,846 shares (Common Stock) at a price of $21.38 per share, resulting in proceeds of $1,536,067. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.51K

Infinity% 3M change

74.81% 12M change

Total Value Held $490,799

Joseph Shulman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 09 2024	BUY Exercise of conversion of derivative security	$1,536,067 $21.38 p/Share	71,846 Added 49.11%	74,460 Common Stock
Feb 01 2024	SELL Open market or private sale	$59,659 $45.06 p/Share	1,324 Reduced 33.62%	2,614 Common Stock
Feb 01 2024	BUY Exercise of conversion of derivative security	-	3,938 Added 50.0%	3,938 Common Stock
Dec 28 2023	SELL Open market or private sale	$396,300 $50.0 p/Share	7,926 Reduced 100.0%	0 Common Stock
Dec 28 2023	BUY Exercise of conversion of derivative security	$145,384 $21.38 p/Share	6,800 Added 46.18%	7,926 Common Stock
Dec 27 2023	SELL Open market or private sale	$250,800 $50.01 p/Share	5,015 Reduced 81.66%	1,126 Common Stock
Dec 27 2023	BUY Exercise of conversion of derivative security	$51,312 $21.38 p/Share	2,400 Added 28.1%	6,141 Common Stock
Nov 14 2023	SELL Open market or private sale	$894,432 $32.07 p/Share	27,890 Reduced 88.17%	3,741 Common Stock
Nov 14 2023	BUY Exercise of conversion of derivative security	$189,652 $6.8 p/Share	27,890 Added 46.86%	31,631 Common Stock
Feb 14 2023	SELL Open market or private sale	$14,885 $26.87 p/Share	554 Reduced 12.9%	3,741 Common Stock
Feb 11 2023	BUY Exercise of conversion of derivative security	-	1,563 Added 26.68%	4,295 Common Stock
Feb 09 2023	SELL Open market or private sale	$25,474 $27.66 p/Share	921 Reduced 25.14%	2,742 Common Stock
Feb 09 2023	BUY Exercise of conversion of derivative security	-	2,657 Added 42.04%	3,663 Common Stock
Feb 15 2022	SELL Open market or private sale	$3,398 $6.1 p/Share	557 Reduced 35.64%	1,006 Common Stock
Feb 11 2022	BUY Exercise of conversion of derivative security	-	1,563 Added 50.0%	1,563 Common Stock

Joseph Shulman

Chief Technical Officer

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RYTM shares.

Notify only if

Value

Insider Trading

Get notified when an Rhythm Pharmaceuticals, Inc. insider buys or sells RYTM shares.

Notify only if

Operation

Value

Type

News

Receive news related to RHYTHM PHARMACEUTICALS, INC.

Track Activities on RYTM

Account